Alkermes (ALKS) Asset Writedowns and Impairment (2010 - 2026)

Alkermes (ALKS) has 17 years of Asset Writedowns and Impairment data on file, last reported at $1.3 million in Q1 2026.

• On a quarterly basis, Asset Writedowns and Impairment rose 372.26% year-over-year to $1.3 million in Q1 2026; TTM through Mar 2026 was $6.3 million, a 146.25% increase from a year earlier, with the FY2025 full-year figure at $5.3 million, up 17.71% from the prior year.
• Asset Writedowns and Impairment for Q1 2026 stood at $1.3 million, up from $915000.0 in the prior quarter.
• Over the last five years, Asset Writedowns and Impairment for ALKS reached as high as $4.9 million in Q4 2023 and fell as low as -$282000.0 in Q4 2024.
• Historically, Asset Writedowns and Impairment has averaged $1.4 million across 5 years, with a median of $915000.0 in 2025.
• Across the five-year window, Asset Writedowns and Impairment slumped 124.53% in 2024 and soared 3860.76% in 2025, its largest moves.
• Year by year, Asset Writedowns and Impairment stood at $1.8 million in 2022, then soared by 176.47% to $4.9 million in 2023, then plunged by 105.71% to -$282000.0 in 2024, then surged by 424.47% to $915000.0 in 2025, then jumped by 41.42% to $1.3 million in 2026.
• Per Business Quant data, the three most recent Asset Writedowns and Impairment figures were $1.3 million in Q1 2026, $915000.0 in Q4 2025, and $1.2 million in Q3 2025.